BR112019000240A2 - composições farmacêuticas - Google Patents
composições farmacêuticasInfo
- Publication number
- BR112019000240A2 BR112019000240A2 BR112019000240-5A BR112019000240A BR112019000240A2 BR 112019000240 A2 BR112019000240 A2 BR 112019000240A2 BR 112019000240 A BR112019000240 A BR 112019000240A BR 112019000240 A2 BR112019000240 A2 BR 112019000240A2
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical compositions
- compositions
- solid
- oils
- preparing
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1611920.8A GB201611920D0 (en) | 2016-07-08 | 2016-07-08 | Pharmaceutical compositions |
| GB1611920.8 | 2016-07-08 | ||
| PCT/EP2017/066983 WO2018015175A1 (en) | 2016-07-08 | 2017-07-06 | Pharmaceutical compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112019000240A2 true BR112019000240A2 (pt) | 2019-04-16 |
Family
ID=56890842
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112019000240-5A BR112019000240A2 (pt) | 2016-07-08 | 2017-07-06 | composições farmacêuticas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20200254046A1 (https=) |
| EP (1) | EP3481377A1 (https=) |
| JP (1) | JP2019520393A (https=) |
| KR (1) | KR20190026816A (https=) |
| CN (1) | CN109414409A (https=) |
| AU (1) | AU2017298873B2 (https=) |
| BR (1) | BR112019000240A2 (https=) |
| CA (1) | CA3029331A1 (https=) |
| CL (1) | CL2019000042A1 (https=) |
| CO (1) | CO2019000083A2 (https=) |
| CR (1) | CR20190007A (https=) |
| DO (1) | DOP2019000002A (https=) |
| EA (1) | EA201990162A1 (https=) |
| GB (1) | GB201611920D0 (https=) |
| IL (1) | IL263999A (https=) |
| MX (1) | MX2019000255A (https=) |
| PE (1) | PE20190321A1 (https=) |
| PH (1) | PH12019500024A1 (https=) |
| SG (1) | SG11201811223YA (https=) |
| WO (1) | WO2018015175A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2022071463A1 (https=) * | 2020-10-02 | 2022-04-07 | ||
| JPWO2022071461A1 (https=) * | 2020-10-02 | 2022-04-07 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005529945A (ja) * | 2002-06-17 | 2005-10-06 | リソルヴィックス ファーマシューティカルズ | オメガ−３ｐｕｆａ由来の脂質メディエーターの類似体及び使用方法 |
| WO2008145183A1 (en) * | 2007-05-30 | 2008-12-04 | Nestec S.A. | Oil-in-water emulsion and its use for the delayed release of active elements |
| GB2465988A (en) * | 2008-12-03 | 2010-06-09 | Omegatri As | Powder or tablet containing unsaturated fatty acid and water insoluble carbohydrate |
| WO2010119319A1 (en) * | 2009-03-09 | 2010-10-21 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof |
| CN102512664B (zh) * | 2010-12-31 | 2015-04-01 | 舒泰神（北京）生物制药股份有限公司 | 一种神经生长因子组合物 |
| UA114615C2 (uk) | 2012-01-06 | 2017-07-10 | Омтера Фармасьютікалз, Інк. | Збагачена дпк композиція омега-3 поліненасичених жирних кислот у формі вільної кислоти |
-
2016
- 2016-07-08 GB GBGB1611920.8A patent/GB201611920D0/en not_active Ceased
-
2017
- 2017-07-06 PE PE2018003289A patent/PE20190321A1/es unknown
- 2017-07-06 JP JP2019500328A patent/JP2019520393A/ja not_active Withdrawn
- 2017-07-06 AU AU2017298873A patent/AU2017298873B2/en not_active Ceased
- 2017-07-06 US US16/316,228 patent/US20200254046A1/en not_active Abandoned
- 2017-07-06 EP EP17737254.7A patent/EP3481377A1/en not_active Withdrawn
- 2017-07-06 WO PCT/EP2017/066983 patent/WO2018015175A1/en not_active Ceased
- 2017-07-06 CA CA3029331A patent/CA3029331A1/en not_active Abandoned
- 2017-07-06 KR KR1020197003215A patent/KR20190026816A/ko not_active Ceased
- 2017-07-06 SG SG11201811223YA patent/SG11201811223YA/en unknown
- 2017-07-06 MX MX2019000255A patent/MX2019000255A/es unknown
- 2017-07-06 EA EA201990162A patent/EA201990162A1/ru unknown
- 2017-07-06 BR BR112019000240-5A patent/BR112019000240A2/pt not_active Application Discontinuation
- 2017-07-06 CN CN201780041970.8A patent/CN109414409A/zh active Pending
- 2017-07-06 CR CR20190007A patent/CR20190007A/es unknown
-
2018
- 2018-12-27 IL IL263999A patent/IL263999A/en unknown
-
2019
- 2019-01-03 PH PH12019500024A patent/PH12019500024A1/en unknown
- 2019-01-03 DO DO2019000002A patent/DOP2019000002A/es unknown
- 2019-01-07 CL CL2019000042A patent/CL2019000042A1/es unknown
- 2019-01-08 CO CONC2019/0000083A patent/CO2019000083A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201811223YA (en) | 2019-01-30 |
| AU2017298873B2 (en) | 2020-04-30 |
| EA201990162A1 (ru) | 2019-06-28 |
| WO2018015175A9 (en) | 2018-03-29 |
| IL263999A (en) | 2019-01-31 |
| PE20190321A1 (es) | 2019-03-04 |
| PH12019500024A1 (en) | 2019-11-04 |
| MX2019000255A (es) | 2019-05-27 |
| CO2019000083A2 (es) | 2019-01-18 |
| EP3481377A1 (en) | 2019-05-15 |
| US20200254046A1 (en) | 2020-08-13 |
| CL2019000042A1 (es) | 2019-04-12 |
| JP2019520393A (ja) | 2019-07-18 |
| KR20190026816A (ko) | 2019-03-13 |
| DOP2019000002A (es) | 2019-03-31 |
| CA3029331A1 (en) | 2018-01-25 |
| CN109414409A (zh) | 2019-03-01 |
| GB201611920D0 (en) | 2016-08-24 |
| AU2017298873A1 (en) | 2019-02-14 |
| CR20190007A (es) | 2019-03-05 |
| WO2018015175A1 (en) | 2018-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2019005379A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
| DOP2019000005A (es) | 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2 | |
| MX2020006150A (es) | Composiciones que comprenden polirribonucleotidos circulares y usos de las mismas. | |
| CL2018003681A1 (es) | Derivados de ácido borónico y usos terapéuticos de los mismos | |
| BR112016026291A2 (pt) | Derivados do ácido borônico e usos terapêuticos dos mesmos | |
| MX390064B (es) | Formas cristalinas de mononucleotido de beta-nicotinamida. | |
| MX2018005708A (es) | Compuesto de 7-(tiazol-5-il)pirrolopirimidina como agonista de tlr7. | |
| MX2016004340A (es) | Compuestos heterociclicos y usos de los mismos. | |
| MX2018013240A (es) | Composiciones antiirritantes sinergisticas de taurina y aloe. | |
| MX2015012379A (es) | Novedosas cepas de lactobacillus y los usos de las mismas. | |
| EA201692334A1 (ru) | Кортикостероидные композиции для местного применения | |
| NI202000028A (es) | Nuevos derivados macrocíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| BR112018013761A2 (pt) | compostos antiproliferativos e suas composições farmacêuticas e usos | |
| DOP2016000170A (es) | Compuestos derivados de hidroxiformamida y usos del mismo | |
| MX2017012596A (es) | Una composicion farmaceutica y el uso de la misma. | |
| DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
| UY35997A (es) | Derivados de isoquinoleína, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| MX391152B (es) | Formulaciones farmaceuticas que comprenden cangrelor de alta pureza y metodos para preparar y utilizar las mismas. | |
| BR112014030720A8 (pt) | composto, composição farmacêutica e usos de inibidores de fbx03 | |
| BR112014031706A8 (pt) | Composições farmacêuticas orais, e composição farmacêutica oral compreendendo itraconazol | |
| CL2016001130A1 (es) | Composiciones sólidas de triglicéridos y usos de estas | |
| CO2021008962A2 (es) | Derivados activos de éster de testosterona, composiciones y usos de los mismos | |
| BR112019000240A2 (pt) | composições farmacêuticas | |
| CL2018002848A1 (es) | Formulaciones liquidas de fosfoplatino | |
| CL2018002368A1 (es) | Formulaciones de oritavancina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
| B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
| B11B | Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements |